| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |